Pakistan vs Yemen: Antiretroviral therapy coverage for PMTCT
Pakistan
14.0%
in 2024
Yemen
11.0%
in 2024
Pakistan rank
81st
Yemen rank
83rd
Antiretroviral therapy coverage for PMTCT over time
- Pakistan
- Yemen
How they compare
Pakistan currently reports 14.0% against 11.0% in Yemen, a difference of 3.0%.
That makes Pakistan's figure about 1.3 times Yemen's.
The two have swapped places 11 times across 24 shared years of data; in 2000 it was Yemen ahead.
Pakistan ranks 81st and Yemen ranks 83rd of 84 countries.
Pakistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Pakistan | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.7% | 0.7% | 0.0% | — |
| 2010s | 7.3% | 4.0% | 3.3% | Pakistan |
| 2020s | 10.4% | 8.8% | 1.6% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Pakistan or Yemen?
- Pakistan, at 14.0% against 11.0% in Yemen as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Pakistan and Yemen?
- 3.0%, with Pakistan ahead.
- How many years of comparable data are there for Pakistan and Yemen?
- 24 years are reported by both, from 2000 to 2024.
- How do Pakistan and Yemen rank globally for antiretroviral therapy coverage for pmtct?
- Pakistan ranks 81st and Yemen ranks 83rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).